Literature DB >> 31823081

Can we Predict Preoperative Tumor Aggressivity with Hemogram Parameters in Renal Cell Carcinoma? a Novel Calculation Method.

Murat Uçar1, Sedat Soyupek2, Taylan Oksay2, Alper Özorak2, Ali Akkoç3, Murat Topçuoğlu3, Murat Demir2, Alim Koşar2.   

Abstract

We aim to investigate the prognostic significance of the hemoglobin X lymphocyte / neutrophil ratio (HLNR) and hemoglobin x lymphocyte / platelet ratio (HLPR) with tumor aggressivity in patients with renal cell carcinoma. We retrospectively analyzed 127 patients' data who had diagnosed as renal cell carcinoma between 2008 and 2019 in Suleyman Demirel University Hospital. Tumor and patient characteristics, hemoglobin, neutrophil, lymphocyte, platelet values HLNR and HLPR were calculated in preoperative hemogram parameters. The relationship between tumor pathological stage, Fuhrman nuclear grade and tumor necrosis with HLPR and HLNR analyzed with statistically. There was a negative correlation between pathologic stage, Fuhrman nuclear grade and tumor necrosis with HLNR. P values are 0.003, 0.012 and 0.015 respectively. HLNR was lower in patients with high pathologic stage, high Fuhrman nuclear grade and accompanying tumor necrosis positiveness. There was a negative correlation between pathologic stage, Fuhrman nuclear grade and tumor necrosis with HLPR. P values are 0.001, 0.014 and 0.047 respectively. HLPR was lower in patients with high pathologic stage, high Fuhrman nuclear grade and accompanying tumor necrosis positiveness. High pathological stage, high Fuhrman nuclear grade and existence of tumor necrosis are associates with preoperative low HLNR and low HLPR in renal cell carcinoma patients. They can be used as prognostic markers in patients with renal mass preoperatively.

Entities:  

Keywords:  Carcinoma renal cell; Hematologic tests; Kidney; Prognosis

Mesh:

Year:  2019        PMID: 31823081     DOI: 10.1007/s10916-019-1491-2

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  28 in total

1.  Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

Authors:  Yoji Kishi; Scott Kopetz; Yun Shin Chun; Martin Palavecino; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2009-01-08       Impact factor: 5.344

2.  Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.

Authors:  Ilaria Lucca; Michela de Martino; Sebastian L Hofbauer; Nura Zamani; Shahrokh F Shariat; Tobias Klatte
Journal:  World J Urol       Date:  2015-04-17       Impact factor: 4.226

3.  Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.

Authors:  Georg C Hutterer; Daniel Krieger; Edvin Mrsic; Kristof Pohlmann; Angelika Bezan; Tatjana Stojakovic; Karl Pummer; Richard Zigeuner; Martin Pichler
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

4.  High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Authors:  Steven C H Kao; Nick Pavlakis; Rozelle Harvie; Janette L Vardy; Michael J Boyer; Nico van Zandwijk; Stephen J Clarke
Journal:  Clin Cancer Res       Date:  2010-10-18       Impact factor: 12.531

5.  Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).

Authors:  Michela de Martino; Tobias Klatte; Christoph Seemann; Matthias Waldert; Andrea Haitel; Georg Schatzl; Mesut Remzi; Peter Weibl
Journal:  BJU Int       Date:  2013-03-15       Impact factor: 5.588

6.  Severe autoimmune hemolytic anemia with renal neoplasm.

Authors:  Emily C Rhodes; Sahil P Parikh; Nishith Bhattacharyya
Journal:  Pediatr Surg Int       Date:  2013-05-16       Impact factor: 1.827

Review 7.  Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.

Authors:  Hariruk Yodying; Akihisa Matsuda; Masao Miyashita; Satoshi Matsumoto; Nobuyuki Sakurazawa; Marina Yamada; Eiji Uchida
Journal:  Ann Surg Oncol       Date:  2015-09-28       Impact factor: 5.344

8.  Renal cell carcinoma with paraneoplastic leucocytosis.

Authors:  Sanjay Kumar Mandal; Jacky Ganguly; Koelina Sil; Soumya Sarathi Mondal; Debasish Sardar; Pankaj Sarkar
Journal:  J Cancer Res Ther       Date:  2015 Jul-Sep       Impact factor: 1.805

9.  Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.

Authors:  S L Hofbauer; K I Stangl; M de Martino; I Lucca; A Haitel; S F Shariat; T Klatte
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

10.  Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.

Authors:  M Pichler; G C Hutterer; C Stoeckigt; T F Chromecki; T Stojakovic; S Golbeck; K Eberhard; A Gerger; S Mannweiler; K Pummer; R Zigeuner
Journal:  Br J Cancer       Date:  2013-02-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.